MedTrace Logo

iPad Technology for HOME Rehabilitation in Patients After Stroke: iHOME Acute/Chronic

NCT01836159 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2019-10-01

No results posted yet for this study

Summary

A pilot randomized, two parallel group study comparing an iPad software game application versus standard care in post-stroke patients.

Study hypothesis: Tablet PC technology using the iPad is a feasible and potentially efficacious tool which has the potential to promote fine motor recovery of the upper extremity after stroke.

Conditions

  • Fine Motor Function Deficit and Visual Neglect Post-stroke

Interventions

OTHER

iPad Intervention

Patients are to self-administer 20 minutes of gaming sessions, in any configuration that is preferred. Patients will be instructed to play the iPad game with the more affected arm/hand. Start and stop times of the iPad intervention will be downloaded from the iPad, which will allow calculation of the total "dose" received. Patients may receive outpatient rehabilitation as required as part of usual care. The 'Stroke Rehab' software for the iPad was specifically designed for patients with either fine motor weakness and/or neglect. It contains 6 stages: 1. Popping a stationary balloon 2. Popping a moving balloon 3. Popping a pair of stationary balloons 4. Popping a pair of moving balloons 5. Stretching a balloon to pop 6. Balloon/Text distraction test

OTHER

Standard/ Usual Care

Patients may receive outpatient rehabilitation as required as part of usual care. Patients will be instructed not to play with an iPad during the 2 week intervention period (in case they have one).

Sponsors & Collaborators

  • Sunnybrook Research Institute

    collaborator OTHER

  • Unity Health Toronto

    lead OTHER

Principal Investigators

  • Tom Schweizer, PhD · Li Ka Shing, St Michael's Hospital

  • Chi-Ming Chow, MD · Unity Health Toronto

  • Gustavo Saposnik, MD, MSc · Unity Health Toronto

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2017-03-31
Completion
2018-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01836159 on ClinicalTrials.gov